IMPROVING CARE FOR DEPRESSION
改善抑郁症护理
基本信息
- 批准号:2250078
- 负责人:
- 金额:$ 62.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1995
- 资助国家:美国
- 起止时间:1995-09-15 至 2000-08-31
- 项目状态:已结题
- 来源:
- 关键词:clinical trials cooperative study decision making health care cost /financing health care model health care personnel performance health care policy health care professional practice health care quality health care service evaluation health care service organization health care service utilization human subject longitudinal human study major depression mental health services patient care personnel attitude peer group primary care physician satisfaction
项目摘要
Major depression is common, debilitating, underrecognized, and
undertreated. Most individuals who do get treatment are cared for solely
in primary care settings. Clinical practice guidelines for depression, in
combination with team-based quality improvement (QI) for implementing
them, offer a potentially valuable tool for improving clinical care and
health outcomes for depressed patients. The main purpose of this study is
to determine whether team-based quality improvement approaches are more
effective than guideline distribution alone for increasing adherence to
guidelines for primary care patients with major depression. As a
secondary purpose, we will assess two common variants of team-based QI.
One of the team-based QI models is more centrally-managed, while the other
is more locally managed. We will thus learn about how, whether, and why
team-based QI works.
We propose a randomized clinical trial in 9 group-practice sites comparing
the central expert (CE) form of QI and the local peer (LP) form of QI to
distribution alone as methods for implementing the recently-published
Agency for Health Care Policy and Research clinical practice guidelines
for depression in primary care. We will evaluate the two QI models in 6
sites (4 autonomous practices within Kaiser Permanente of Northern
California and 2 firm (team) practices at the Sepulveda VA Medical Center)
against a control condition--guideline distribution--in 3 sites (2 Kaiser
and 1 Sepulveda VA practice). The QI approaches will be implemented over
a 10 month period. To evaluate the effectiveness of the QI approaches, we
will enroll 750 depressed patients during the post intervention period,
distributed across study sites. We will assess patient health status
(including severity of depression) and the quality of the process of care
for depression for both samples. We will follow these patients for 12
months to determine their health and cost outcomes and their satisfaction
with care. We will also assess health and cost outcomes and their
satisfaction with care. We will also assess health care provider
attitudes and knowledge, as well as any organizational features that
affect the success of the interventions. The study will thus generate new
knowledge about guidelines implementation for depression, quality
improvement methods, and the barriers and resources for depression care in
primary care settings.
重度抑郁很常见,使人衰弱,不认可,并且
治疗不足。大多数获得治疗的人都只照顾
在初级保健环境中。抑郁症临床实践指南,
结合实施的基于团队的质量改进(QI)
他们提供了一种潜在的有价值的工具来改善临床护理和
抑郁症患者的健康结果。这项研究的主要目的是
确定基于团队的质量改进方法是否更多
比单独的指南分布有效,以提高依从性
大抑郁症的初级保健患者指南。作为
次要目的,我们将评估两个基于团队的气的常见变体。
基于团队的QI模型之一是更集中管理的,而另一个
是在本地管理的。因此,我们将了解如何,是否以及为什么
基于团队的Qi作品。
我们在9个小组实践地点提出了一项随机临床试验,以比较
Qi的中央专家(CE)形式和当地同行(LP)Qi形式
仅分发作为实施最近发布的方法
卫生保健政策和研究局临床实践指南
用于初级保健的抑郁症。我们将在6中评估两个Qi模型
站点(北部Kaiser Permanente内的4种自主做法
加利福尼亚和2个公司(团队)练习在塞普维达弗吉尼亚州医疗中心)
在3个地点(2个Kaiser)
和1 Sepulveda VA实践)。 QI方法将被实施
一个10个月的时间。为了评估QI方法的有效性,我们
在干预后,将招募750名抑郁症患者,
分布在研究地点。我们将评估患者健康状况
(包括抑郁的严重程度)和护理过程的质量
两个样品的抑郁症。我们将跟随这些患者12
确定其健康和成本成果和满意度的月份
小心。我们还将评估健康和成本成果及其
对护理的满意。我们还将评估医疗保健提供者
态度和知识以及任何组织特征
影响干预措施的成功。因此,该研究将产生新的
有关抑郁,质量实施准则的知识
改进方法以及抑郁症护理的障碍和资源
初级保健设置。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LISA V RUBENSTEIN其他文献
LISA V RUBENSTEIN的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LISA V RUBENSTEIN', 18)}}的其他基金
EXPERT PANEL MEETING ADVANCING THE SCIENCE OF CONTINUOUS QUALITY IMPROVEMENT
专家小组会议推进持续质量改进的科学
- 批准号:
7753123 - 财政年份:2009
- 资助金额:
$ 62.75万 - 项目类别:
相似国自然基金
电商助农中公益营销、合作模式与质量决策研究
- 批准号:72371107
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
城市公用事业智能化转型合作的决策模型和实现机制研究:基于政府与企业合作的治理视角
- 批准号:72304166
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
政府与社会资本合作政策不确定性对民营企业投资决策的影响:逆向混改视角下的研究
- 批准号:72304022
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于合作型强化学习算法的纯电动汽车连续决策优化研究
- 批准号:62302326
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
需求新鲜度关联下易逝品供应链决策与合作机制研究
- 批准号:72371127
- 批准年份:2023
- 资助金额:41 万元
- 项目类别:面上项目
相似海外基金
Shaping the Indications for Periodontal Adjunctive Antibiotics in Dental Practice: A PBRN Clinical Trial
确定牙科实践中牙周辅助抗生素的适应症:PBRN 临床试验
- 批准号:
10448940 - 财政年份:2022
- 资助金额:
$ 62.75万 - 项目类别:
VA Aripiprazole vs. Esketamine for Treatment of Depression VAST-D II
VA 阿立哌唑与艾氯胺酮治疗抑郁症 VAST-D II
- 批准号:
10426080 - 财政年份:2021
- 资助金额:
$ 62.75万 - 项目类别:
Pharmacogenetic discovery in the GRADE comparative effectiveness type 2 diabetes clinical trial
GRADE 2 型糖尿病有效性比较临床试验中的药物遗传学发现
- 批准号:
10378153 - 财政年份:2021
- 资助金额:
$ 62.75万 - 项目类别: